 | • レポートコード：GIR-105X04893 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、107ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Pharma & Healthcare |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、ダラツムマブのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。ダラツムマブの種類別市場規模（100mg注射、400mg注射）、用途別市場規模（多発性骨髄腫、びまん性大細胞型B細胞リンパ腫、濾胞性リンパ腫、マントル細胞リンパ腫、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・ダラツムマブの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Johnson＆Johnson ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：100mg注射、400mg注射 ・用途別分析2016年-2026年：多発性骨髄腫、びまん性大細胞型B細胞リンパ腫、濾胞性リンパ腫、マントル細胞リンパ腫、その他 ・ダラツムマブの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・ダラツムマブのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・ダラツムマブのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・ダラツムマブの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・ダラツムマブの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Daratumumab market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Daratumumab size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Daratumumab market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Daratumumab market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
100mg Injection
400mg Injection
Market segment by Application can be divided into
Multiple Myeloma
Diffuse Large B Cell Lymphoma
Follicular Lymphoma
Mantle Cell Lymphoma
Other
The key market players for global Daratumumab market are listed below:
Johnson＆Johnson
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Daratumumab Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Daratumumab Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 100mg Injection
1.2.3 400mg Injection
1.3 Market Analysis by Application
1.3.1 Overview: Global Daratumumab Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Multiple Myeloma
1.3.3 Diffuse Large B Cell Lymphoma
1.3.4 Follicular Lymphoma
1.3.5 Mantle Cell Lymphoma
1.3.6 Other
1.4 Global Daratumumab Market Size & Forecast
1.4.1 Global Daratumumab Sales in Value (2016-2026))
1.4.2 Global Daratumumab Sales in Volume (2016-2026)
1.4.3 Global Daratumumab Price by Type (2016-2026) & (USD/Pcs)
1.5 Global Daratumumab Production Capacity Analysis
1.5.1 Global Daratumumab Total Production Capacity (2016-2026)
1.5.2 Global Daratumumab Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Daratumumab Market Drivers
1.6.2 Daratumumab Market Restraints
1.6.3 Daratumumab Trends Analysis
2 Manufacturers Profiles
2.1 Johnson＆Johnson
2.1.1 Johnson＆Johnson Details
2.1.2 Johnson＆Johnson Major Business
2.1.3 Johnson＆Johnson Daratumumab Product and Services
2.1.4 Johnson＆Johnson Daratumumab Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Daratumumab Sales by Manufacturer
3.1 Global Daratumumab Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Daratumumab Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Daratumumab
3.4 Market Concentration Rate
3.4.1 Top 3 Daratumumab Manufacturer Market Share
3.4.2 Top 6 Daratumumab Manufacturer Market Share
3.5 Global Daratumumab Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Daratumumab Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Daratumumab Market Size by Region
4.1.1 Global Daratumumab Sales in Volume by Region (2016-2026)
4.1.2 Global Daratumumab Revenue by Region (2016-2026)
4.2 North America Daratumumab Revenue (2016-2026)
4.3 Europe Daratumumab Revenue (2016-2026)
4.4 Asia-Pacific Daratumumab Revenue (2016-2026)
4.5 South America Daratumumab Revenue (2016-2026)
4.6 Middle East and Africa Daratumumab Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Daratumumab Sales in Volume by Type (2016-2026)
5.2 Global Daratumumab Revenue by Type (2016-2026)
5.3 Global Daratumumab Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Daratumumab Sales in Volume by Application (2016-2026)
6.2 Global Daratumumab Revenue by Application (2016-2026)
6.3 Global Daratumumab Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Daratumumab Sales by Type (2016-2026)
7.2 North America Daratumumab Sales by Application (2016-2026)
7.3 North America Daratumumab Market Size by Country
7.3.1 North America Daratumumab Sales in Volume by Country (2016-2026)
7.3.2 North America Daratumumab Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Daratumumab Sales by Type (2016-2026)
8.2 Europe Daratumumab Sales by Application (2016-2026)
8.3 Europe Daratumumab Market Size by Country
8.3.1 Europe Daratumumab Sales in Volume by Country (2016-2026)
8.3.2 Europe Daratumumab Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Daratumumab Sales by Type (2016-2026)
9.2 Asia-Pacific Daratumumab Sales by Application (2016-2026)
9.3 Asia-Pacific Daratumumab Market Size by Region
9.3.1 Asia-Pacific Daratumumab Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Daratumumab Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Daratumumab Sales by Type (2016-2026)
10.2 South America Daratumumab Sales by Application (2016-2026)
10.3 South America Daratumumab Market Size by Country
10.3.1 South America Daratumumab Sales in Volume by Country (2016-2026)
10.3.2 South America Daratumumab Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Daratumumab Sales by Type (2016-2026)
11.2 Middle East & Africa Daratumumab Sales by Application (2016-2026)
11.3 Middle East & Africa Daratumumab Market Size by Country
11.3.1 Middle East & Africa Daratumumab Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Daratumumab Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Daratumumab Typical Distributors
12.3 Daratumumab Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Daratumumab Revenue by Type, (USD Million), 2021-2026
Table 2. Global Daratumumab Revenue by Application, (USD Million), 2021-2026
Table 3. Johnson＆Johnson Basic Information, Manufacturing Base and Competitors
Table 4. Johnson＆Johnson Major Business
Table 5. Johnson＆Johnson Daratumumab Product and Services
Table 6. Johnson＆Johnson Daratumumab Sales (K Pcs), Price (USD/Pcs), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Global Daratumumab Sales by Manufacturer (2019-2021e) & (K Pcs)
Table 8. Global Daratumumab Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 9. Market Position of Manufacturers in Daratumumab, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 10. Global Daratumumab Production Capacity by Company, (K Pcs): 2020 VS 2021
Table 11. Head Office and Daratumumab Production Site of Key Manufacturer
Table 12. Global Daratumumab Sales by Region (2016-2021e) & (K Pcs)
Table 13. Global Daratumumab Sales by Region (2021-2026) & (K Pcs)
Table 14. Global Daratumumab Revenue by Region (2016-2021e) & (USD Million)
Table 15. Global Daratumumab Revenue by Region (2021-2026) & (USD Million)
Table 16. Global Daratumumab Sales by Type (2016-2021e) & (K Pcs)
Table 17. Global Daratumumab Sales by Type (2021-2026) & (K Pcs)
Table 18. Global Daratumumab Revenue by Type (2016-2021e) & (USD Million)
Table 19. Global Daratumumab Revenue by Type (2021-2026) & (USD Million)
Table 20. Global Daratumumab Price by Type (2016-2021e) & (USD/Pcs)
Table 21. Global Daratumumab Price by Type (2021-2026) & (USD/Pcs)
Table 22. Global Daratumumab Sales by Application (2016-2021e) & (K Pcs)
Table 23. Global Daratumumab Sales by Application (2021-2026) & (K Pcs)
Table 24. Global Daratumumab Revenue by Application (2016-2021e) & (USD Million)
Table 25. Global Daratumumab Revenue by Application (2021-2026) & (USD Million)
Table 26. Global Daratumumab Price by Application (2016-2021e) & (USD/Pcs)
Table 27. Global Daratumumab Price by Application (2021-2026) & (USD/Pcs)
Table 28. North America Daratumumab Sales by Country (2016-2021e) & (K Pcs)
Table 29. North America Daratumumab Sales by Country (2021-2026) & (K Pcs)
Table 30. North America Daratumumab Revenue by Country (2016-2021e) & (USD Million)
Table 31. North America Daratumumab Revenue by Country (2021-2026) & (USD Million)
Table 32. North America Daratumumab Sales by Type (2016-2021e) & (K Pcs)
Table 33. North America Daratumumab Sales by Type (2021-2026) & (K Pcs)
Table 34. North America Daratumumab Sales by Application (2016-2021e) & (K Pcs)
Table 35. North America Daratumumab Sales by Application (2021-2026) & (K Pcs)
Table 36. Europe Daratumumab Sales by Country (2016-2021e) & (K Pcs)
Table 37. Europe Daratumumab Sales by Country (2021-2026) & (K Pcs)
Table 38. Europe Daratumumab Revenue by Country (2016-2021e) & (USD Million)
Table 39. Europe Daratumumab Revenue by Country (2021-2026) & (USD Million)
Table 40. Europe Daratumumab Sales by Type (2016-2021e) & (K Pcs)
Table 41. Europe Daratumumab Sales by Type (2021-2026) & (K Pcs)
Table 42. Europe Daratumumab Sales by Application (2016-2021e) & (K Pcs)
Table 43. Europe Daratumumab Sales by Application (2021-2026) & (K Pcs)
Table 44. Asia-Pacific Daratumumab Sales by Region (2016-2021e) & (K Pcs)
Table 45. Asia-Pacific Daratumumab Sales by Region (2021-2026) & (K Pcs)
Table 46. Asia-Pacific Daratumumab Revenue by Region (2016-2021e) & (USD Million)
Table 47. Asia-Pacific Daratumumab Revenue by Region (2021-2026) & (USD Million)
Table 48. Asia-Pacific Daratumumab Sales by Type (2016-2021e) & (K Pcs)
Table 49. Asia-Pacific Daratumumab Sales by Type (2021-2026) & (K Pcs)
Table 50. Asia-Pacific Daratumumab Sales by Application (2016-2021e) & (K Pcs)
Table 51. Asia-Pacific Daratumumab Sales by Application (2021-2026) & (K Pcs)
Table 52. South America Daratumumab Sales by Country (2016-2021e) & (K Pcs)
Table 53. South America Daratumumab Sales by Country (2021-2026) & (K Pcs)
Table 54. South America Daratumumab Revenue by Country (2016-2021e) & (USD Million)
Table 55. South America Daratumumab Revenue by Country (2021-2026) & (USD Million)
Table 56. South America Daratumumab Sales by Type (2016-2021e) & (K Pcs)
Table 57. South America Daratumumab Sales by Type (2021-2026) & (K Pcs)
Table 58. South America Daratumumab Sales by Application (2016-2021e) & (K Pcs)
Table 59. South America Daratumumab Sales by Application (2021-2026) & (K Pcs)
Table 60. Middle East & Africa Daratumumab Sales by Country (2016-2021e) & (K Pcs)
Table 61. Middle East & Africa Daratumumab Sales by Country (2021-2026) & (K Pcs)
Table 62. Middle East & Africa Daratumumab Revenue by Country (2016-2021e) & (USD Million)
Table 63. Middle East & Africa Daratumumab Revenue by Country (2021-2026) & (USD Million)
Table 64. Middle East & Africa Daratumumab Sales by Type (2016-2021e) & (K Pcs)
Table 65. Middle East & Africa Daratumumab Sales by Type (2021-2026) & (K Pcs)
Table 66. Middle East & Africa Daratumumab Sales by Application (2016-2021e) & (K Pcs)
Table 67. Middle East & Africa Daratumumab Sales by Application (2021-2026) & (K Pcs)
Table 68. Direct Channel Pros & Cons
Table 69. Indirect Channel Pros & Cons
Table 70. Daratumumab Typical Distributors
Table 71. Daratumumab Typical Customers
List of Figures
Figure 1. Daratumumab Picture
Figure 2. Global Daratumumab Sales Market Share by Type in 2020
Figure 3. 100mg Injection
Figure 4. 400mg Injection
Figure 5. Global Daratumumab Sales Market Share by Application in 2020
Figure 6. Multiple Myeloma
Figure 7. Diffuse Large B Cell Lymphoma
Figure 8. Follicular Lymphoma
Figure 9. Mantle Cell Lymphoma
Figure 10. Other
Figure 11. Global Daratumumab Market Size, (USD Million) & (K Pcs): 2020 VS 2021 VS 2026
Figure 12. Global Daratumumab Market Size and Forecast (2016-2026) & (USD Million)
Figure 13. United States Daratumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Canada Daratumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. Mexico Daratumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. Germany Daratumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. France Daratumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. United Kingdom Daratumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. Russia Daratumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Italy Daratumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. China Daratumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. Japan Daratumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Korea Daratumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. India Daratumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Southeast Asia Daratumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Australia Daratumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Brazil Daratumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. Egypt Daratumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Saudi Arabia Daratumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. South Africa Daratumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 31. Turkey Daratumumab Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 32. Global Daratumumab Sales (2016-2026) & (K Pcs)
Figure 33. Global Daratumumab Production Capacity (2016-2026) & (K Pcs)
Figure 34. Global Daratumumab Production Capacity by Geographic Region: 2020 VS 2021
Figure 35. Daratumumab Market Drivers
Figure 36. Daratumumab Market Restraints
Figure 37. Daratumumab Market Trends
Figure 38. Global Daratumumab Sales Market Share by Manufacturer in 2020
Figure 39. Global Daratumumab Revenue Market Share by Manufacturer in 2020
Figure 40. Daratumumab Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 41. Top 3 Daratumumab Manufacturer (Revenue) Market Share in 2020
Figure 42. Top 6 Daratumumab Manufacturer (Revenue) Market Share in 2020
Figure 43. Global Daratumumab Sales Market Share by Region (2016-2026)
Figure 44. Global Daratumumab Revenue Market Share by Region (2016-2026)
Figure 45. North America Daratumumab Revenue (2016-2026) & (USD Million)
Figure 46. Europe Daratumumab Revenue (2016-2026) & (USD Million)
Figure 47. Asia-Pacific Daratumumab Revenue (2016-2026) & (USD Million)
Figure 48. South America Daratumumab Revenue (2016-2026) & (USD Million)
Figure 49. Middle East & Africa Daratumumab Revenue (2016-2026) & (USD Million)
Figure 50. Global Daratumumab Sales Market Share by Type (2016-2026)
Figure 51. Global Daratumumab Revenue Market Share by Type (2016-2026)
Figure 52. Global Daratumumab Price by Type (2016-2026) & (USD/Pcs)
Figure 53. Global Daratumumab Sales Market Share by Application (2016-2026)
Figure 54. Global Daratumumab Revenue Market Share by Application (2016-2026)
Figure 55. Global Daratumumab Price by Application (2016-2026) & (USD/Pcs)
Figure 56. North America Daratumumab Sales Market Share by Country (2016-2026)
Figure 57. North America Daratumumab Revenue Market Share by Country (2016-2026)
Figure 58. North America Daratumumab Sales Market Share by Type (2016-2026)
Figure 59. North America Daratumumab Sales Market Share by Application (2016-2026)
Figure 60. Europe Daratumumab Sales Market Share by Country (2016-2026)
Figure 61. Europe Daratumumab Revenue Market Share by Country (2016-2026)
Figure 62. Europe Daratumumab Sales Market Share by Type (2016-2026)
Figure 63. Europe Daratumumab Sales Market Share by Application (2016-2026)
Figure 64. Asia-Pacific Daratumumab Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Daratumumab Revenue Market Share by Region (2016-2026)
Figure 66. Asia-Pacific Daratumumab Sales Market Share by Region (2016-2026)
Figure 67. Asia-Pacific Daratumumab Sales Market Share by Application (2016-2026)
Figure 68. South America Daratumumab Sales Market Share by Country (2016-2026)
Figure 69. South America Daratumumab Revenue Market Share by Country (2016-2026)
Figure 70. South America Daratumumab Sales Market Share by Type (2016-2026)
Figure 71. South America Daratumumab Sales Market Share by Application (2016-2026)
Figure 72. Middle East & Africa Daratumumab Sales Market Share by Country (2016-2026)
Figure 73. Middle East & Africa Daratumumab Revenue Market Share by Country (2016-2026)
Figure 74. Middle East & Africa Daratumumab Sales Market Share by Type (2016-2026)
Figure 75. Middle East & Africa Daratumumab Sales Market Share by Application (2016-2026)
Figure 76. Sales Channel: Direct Channel vs Indirect Channel
Figure 77. Methodology
Figure 78. Research Process and Data Source
世界の未分化大細胞リンパ腫治療薬市場 2021：企業別、地域別、種類・用途別 The Anaplastic Large Cell Lymphoma Drugs market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, …- ホジキンリンパ腫治療の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Hodgkin's Lymphoma (HL) is defined as the cancer of the lymph tissue, which is part of our immune system. The exact etiology of HL is unknown. However, the risk of developing the condition is increased if a person suffers from a medical condition that weakens the immune system. In HL, cells in the l…
- 非ホジキンリンパ腫（NHL）の世界市場2018-2025 Non-Hodgkin Lymphoma is the most common lymphoma which affects large number of people. It begins in lymphocytes present in lymph nodes of body parts such as neck or chest or under the arms. It widely spreads to the other lymph nodes and to other organs such as bone marrow, lungs, or liver.In 2018, t…
- 世界の未分化リンパ腫キナーゼ阻害剤市場 2021：企業別、地域別、種類・用途別 The Anaplastic Lymphoma Kinase Inhibitors market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization,…
- 多発性硬化症に対する幹細胞療法の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Multiple sclerosis is a nervous system disease, triggered by unidentified environmental factors that adversely affects the brain and spinal cord. It damages the myelin sheath that surrounds and protects the nerve cells. Some of the symptoms of the disease includes weakness, numbness, blurred vision,…